claim: algernon retains novotech in trial of ifenprodil in covid-19 patients
evidence_1: march 23, 2020 algernon appoints u.s. based cascade chemistry to support its quickly evolving clinical program for ali, its urgent clinical focus on covid-19 as well as its idiopathic pulmonary fibrosis (ipf) and chronic cough clinical program.", "march 20, 2020 algernon appoints award winning novotech as the contract research organization (cro) for a planned physician-initiated study of ifenprodil for covid-19 patients in south korea.")